Status:
RECRUITING
PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Eligibility:
All Genders
18+ years
Brief Summary
Understanding Delays in the Diagnosis of Pulmonary Arterial Hypertension and Rare Diseases in Brazil: A Multicenter Observational Study \--- Pulmonary arterial hypertension (PAH) is a rare, progressi...
Detailed Description
Background and Rationale: Pulmonary arterial hypertension (PAH) is a rare condition characterized by progressive elevation of pulmonary artery pressure, leading to right ventricular dysfunction and d...
Eligibility Criteria
Inclusion
- Availability of documented or estimated date of first symptom suggestive of PAH.
- Availability of documented date of confirmed PAH diagnosis.
Exclusion
- Patients with pulmonary hypertension not classified as Group 1 (e.g., due to left heart disease, chronic lung disease, or chronic thromboembolic disease).
- Patients with insufficient data to determine either the date of symptom onset or the date of confirmed diagnosis.
- Patients diagnosed only clinically or by echocardiography, without confirmation by right heart catheterization.
Key Trial Info
Start Date :
July 7 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT06998329
Start Date
July 7 2025
End Date
December 1 2027
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
InCor - Universidade de São Paulo
São Paulo, São Paulo, Brazil, 05048000